Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -259.91% is 356% below its 5-year average of -57.05%, near the low end of its 5-year range (-259.91%–-25.64%).
As of the fiscal period ended Tuesday, June 30, 2026. 35.60% below its 12-month average of -191.67%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -259.91%.
RETURN ON INVESTED CAPITAL (ROIC)
-259.91%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-191.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-115.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-57.05%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-35.60%
CURRENT VS 3Y AVG
-125.42%
CURRENT VS 5Y AVG
-355.62%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-628.85%
vs the sector median at left
NextCure, Inc.
Market Cap
$20.53M
Return on Invested Capital (ROIC)
-259.91%
TTM Avg
-191.67%
3Y Avg
-115.30%
5Y Avg
-57.05%
Market Cap
$19.77M
Return on Invested Capital (ROIC)
-27.14%
TTM Avg
-181.80%
3Y Avg
-158.13%
5Y Avg
-129.64%
Market Cap
$19.42M
Return on Invested Capital (ROIC)
-1489.99%
TTM Avg
-2573.36%
3Y Avg
-1757.31%
5Y Avg
-1757.31%
Market Cap
$22.00M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-12.54%
3Y Avg
-12.42%
5Y Avg
-37.50%
Market Cap
$22.25M
Return on Invested Capital (ROIC)
-253.57%
TTM Avg
-160.85%
3Y Avg
-171.27%
5Y Avg
-226.34%
Market Cap
$18.65M
Return on Invested Capital (ROIC)
-49.83%
TTM Avg
-1.54%
3Y Avg
-82.67%
5Y Avg
-67.29%
Market Cap
$18.41M
Return on Invested Capital (ROIC)
-51.68%
TTM Avg
-130.81%
3Y Avg
-134.17%
5Y Avg
-120.84%
Market Cap
$22.68M
Return on Invested Capital (ROIC)
-248.21%
TTM Avg
-225.06%
3Y Avg
-147.38%
5Y Avg
-102.77%
Market Cap
$18.30M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-171.06%
3Y Avg
-106.73%
5Y Avg
-106.73%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NextCure, Inc. (NXTC) | $20.53M | -259.91% | -191.67% | -115.30% | -57.05% |
| Quantum BioPharma Ltd. (QNTM)vs › | $19.77M | -27.14% | -181.80% | -158.13% | -129.64% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.42M | -1489.99% | -2573.36% | -1757.31% | -1757.31% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.00M | -14.21% | -12.54% | -12.42% | -37.50% |
| Modular Medical, Inc. (MODD)vs › | $22.25M | -253.57% | -160.85% | -171.27% | -226.34% |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | -49.83% | -1.54% | -82.67% | -67.29% |
| P3 Health Partners Inc. (PIII)vs › | $18.41M | -51.68% | -130.81% | -134.17% | -120.84% |
| LeonaBio, Inc. (LONA)vs › | $22.68M | -248.21% | -225.06% | -147.38% | -102.77% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.30M | N/A | -171.06% | -106.73% | -106.73% |
| Rein Therapeutics Inc. (RNTX)vs › | $23.06M | -36.89% | -112.27% | -56.18% | -37.49% |
ROIC
-259.9%
ROE
-351.9%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -259.91% |
| 2026-03-31 | -174.59% |
| 2025-12-31 | -145.43% |
| 2025-09-30 | -208.32% |
| 2025-06-30 | -170.09% |
| 2025-03-31 | -85.14% |
| 2024-12-31 | -83.81% |
| 2024-09-30 | -76.97% |
| 2024-06-30 | -71.71% |
| 2024-03-31 | -64.71% |
| 2023-12-31 | -55.83% |
| 2023-09-30 | -52.08% |
| 2023-06-30 | -50.32% |
| 2023-03-31 | -44.49% |
| 2022-12-31 | -43.37% |
| 2022-09-30 | -40.87% |
| 2022-06-30 | -37.11% |
| 2022-03-31 | -34.35% |
| 2021-12-31 | -30.01% |
| 2021-09-30 | -27.92% |
| 2021-06-30 | -25.64% |
| 2021-03-31 | -23.44% |
| 2020-12-31 | -13.83% |
| 2020-09-30 | -11.86% |
| 2020-06-30 | -8.97% |
| 2020-03-31 | -6.66% |
| 2019-12-31 | -10.93% |
| 2019-09-30 | -16.79% |
| 2019-06-30 | -14.16% |
| 2019-03-31 | -18.47% |
| 2018-12-31 | -16.84% |
